Each Tuesday, we reverse-engineer a real SaaS company's revenue, profit, CAC, funnels, and its top growth tactic.
Sign up to access all features
Sign up with GoogleSign up with LinkedInAlready have an account? Log in
GetLatka is trusted by 200k+ founders, researchers, and marketers.
No contracts, cancel at any time
InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.
Last updated
In 2024, Oxford Drug Design's revenue reached $2.7M. The company previously reported $1.4M in 2023. Since its launch in 2001, Oxford Drug Design has shown consistent revenue growth.
Oxford Drug Design has not publicly disclosed its valuation. The company has raised $12.4M in total funding to date.
Oxford Drug Design has raised $12.4M in total funding across 5 rounds, most recently a $2.7M Convertible Note round in 2022.
| Year | Round | Amount | Valuation | % Sold | Source |
|---|---|---|---|---|---|
| 2022 | Convertible Note | $2.7M | - | - | |
| 2019 | Venture Round | $2.7M | - | - | |
| 2019 | Grant |
| Question | Answer |
|---|---|
| What's your age? | - |
| Favorite online tool? | - |
| Favorite book? | - |
| Favorite CEO? | - |
| Advice for 20 year old self | - |
We do not have customer count information for Oxford Drug Design yet.
Oxford Drug Design employs approximately 11 people as of 2026.
Oxford Drug Design generates an estimated $2.7M in annual revenue.
Oxford Drug Design was founded by Graham Richards.
The CEO of Oxford Drug Design is Graham Richards.
Oxford Drug Design raised $12.4M across 5 rounds.
Oxford Drug Design has 11 employees.
Oxford Drug Design is headquartered in Oxford, United Kingdom.
Oxford Drug Design operates across multiple industries. Browse revenue, funding, and growth data for Oxford Drug Design in each sector below.
All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.
Claim this profile
Discovered Labs is an AI-native agency specializing in Answer Engine Optimization (AEO) and Search...
B2B SaaS powered by AI that makes crop predictions (best harvesting time, plant diseases...)...
Enterprise-grade banking APIs
Developer of remote sensing technologies designed to reduce maintenance costs without compromising...
2024 Revenue
$2.7M(Est.)
Funding
$12.4M
Team
11
Founded
2001
| Year | Milestone | Source |
|---|---|---|
| 2024 | Oxford Drug Design Hit $2.7m revenue in October 2024 | Estimated |
| 2023 | Oxford Drug Design Hit $1.4m revenue in November 2023 | Estimated |
| 2022 | Oxford Drug Design Hit $1.1m revenue in November 2022 | |
| 2022 | Oxford Drug Design Hit $1.1m revenue in May 2022 | |
| 2021 | Oxford Drug Design Hit $709.9k revenue in November 2021 | |
| 2021 | Oxford Drug Design Hit $709.9k revenue in April 2021 | |
| 2001 | Launched with $0 revenue |
| $3.2M |
| - |
| - |
| 2017 | Series A | $1.2M | - | - |
| 2006 | Venture Round | $2.4M | - | - |
| Year | Milestone | Source |
|---|---|---|
| 2024 | Reached 11 employees (October 2024) | |
| 2023 | Reached 11 employees (November 2023) | |
| 2022 | Reached 9 employees (November 2022) | |
| 2022 | Reached 9 employees (May 2022) | |
| 2021 | Reached 7 employees (November 2021) | |
| 2021 | Reached 25 employees (April 2021) | |
| 2020 | Reached 7 employees (November 2020) |
If you're the CEO and would like to join the podcast, please DM Nathan Latka on LinkedIn.
